Abstract
Background: Andrographolide, a labdone diterpene extracted from Andrographis paniculata possesses various medicinal properties and has been used in treatment of number of chronic diseases, in humans.
Objectives: Evaluation of the effects of andrographolide on COX-2 enzyme (in silico and in vitro studies).
Materials and Methods: The interactions of andrographolide with COX-2 protein were evaluated (in silico) by molecular docking using Auto Dock Vina, version 4.0 software and visualized using pyMOL. An isocratic based HPLC method was developed for characterization of the purified andrographolide using mobile phase [methanol: water: acetonitrile (65:10:25)] and its UV absorption at different wavelengths. This compound was further tested in vitro against human recombinant COX-2 enzyme for its effect at various concentrations (10, 25, 50, 75, 100, 150, 200 nM). Celecoxib was used as a reference standard for comparison in both studies.
Results: The in silico studies revealed that andrographolide exhibited higher binding score of -10.3 K cal/mol and formation of hydrogen bonds with His 90 and Arg 120 amino acid residues of COX-2 indicating its binding to the protein. A relatively rapid, accurate and precise HPLC method was developed for andrographolide with the retention time of 3.255 min. The in vitro studies revealed a concentration dependent inhibitory effect of andrographolide on the COX-2 activity with an IC50 value of 50 nM.
Conclusion: Our studies confirmed the inhibitory effects of andrographolide on COX-2 enzyme (in silico and in vitro), as the basis for its anti-inflammatory potentials.
Keywords: Andrographolide, anti-inflammatory agents, cyclooxygenase-2, celecoxib.
Graphical Abstract
Current Bioactive Compounds
Title:Inhibitory Action of Andrographolide on Cyclooxygenase-2 Enzyme Activity: In Silico and In Vitro Studies
Volume: 12 Issue: 1
Author(s): Deepika Godugu, Karuna Rupula and Sashidhar Rao Beedu
Affiliation:
Keywords: Andrographolide, anti-inflammatory agents, cyclooxygenase-2, celecoxib.
Abstract: Background: Andrographolide, a labdone diterpene extracted from Andrographis paniculata possesses various medicinal properties and has been used in treatment of number of chronic diseases, in humans.
Objectives: Evaluation of the effects of andrographolide on COX-2 enzyme (in silico and in vitro studies).
Materials and Methods: The interactions of andrographolide with COX-2 protein were evaluated (in silico) by molecular docking using Auto Dock Vina, version 4.0 software and visualized using pyMOL. An isocratic based HPLC method was developed for characterization of the purified andrographolide using mobile phase [methanol: water: acetonitrile (65:10:25)] and its UV absorption at different wavelengths. This compound was further tested in vitro against human recombinant COX-2 enzyme for its effect at various concentrations (10, 25, 50, 75, 100, 150, 200 nM). Celecoxib was used as a reference standard for comparison in both studies.
Results: The in silico studies revealed that andrographolide exhibited higher binding score of -10.3 K cal/mol and formation of hydrogen bonds with His 90 and Arg 120 amino acid residues of COX-2 indicating its binding to the protein. A relatively rapid, accurate and precise HPLC method was developed for andrographolide with the retention time of 3.255 min. The in vitro studies revealed a concentration dependent inhibitory effect of andrographolide on the COX-2 activity with an IC50 value of 50 nM.
Conclusion: Our studies confirmed the inhibitory effects of andrographolide on COX-2 enzyme (in silico and in vitro), as the basis for its anti-inflammatory potentials.
Export Options
About this article
Cite this article as:
Godugu Deepika, Rupula Karuna and Rao Beedu Sashidhar, Inhibitory Action of Andrographolide on Cyclooxygenase-2 Enzyme Activity: In Silico and In Vitro Studies, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160310235908
DOI https://dx.doi.org/10.2174/1573407212666160310235908 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design A Neural Network-Based QSAR Approach for Exploration of Diverse Multi-Tyrosine Kinase Inhibitors and its Comparison with a Fragment- Based Approach
Current Computer-Aided Drug Design Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets Cognitive Impairment Associated with Parkinson’s Disease: Role of Mitochondria
Current Neuropharmacology Strategies to Improve Insulin Delivery through Oral Route: A Review
Current Drug Delivery Levamisole-Induced Leukoencephalopathy in Russia: Analysis of 30 Cases
Current Drug Safety Treatment for Cancer Patients with Oral Mucositis: Assessment Based on the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer in International Society of Oral Oncology (MASCC/ISOO) in 2013 and Proposal of Possible Novel Treatment with a Japanese Herbal Medicine
Current Pharmaceutical Design The Application of DNA Microarrays to the Study of Cancer
Current Genomics Why Some Messages Speak Better: Child Immunization in the News and on the Internet
Current Drug Safety Beneficial and Detrimental Effects of Antioxidants Use in Sports: How is it Balanced?
Current Nutraceuticals The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment
Current Medicinal Chemistry Design, Synthesis and Evaluation of Novel 2-piperidinyl Quinoline Chalcones/ Amines as Potential Antidepressant Agents
Letters in Drug Design & Discovery Synthesis and Anticancer Activity of 1, 3, 5-Triaryl-1H-Pyrazole
Letters in Drug Design & Discovery Isolation and Structural Elucidation of Antioxidant Peptides from Oyster (Saccostrea cucullata) Protein Hydrolysate
Protein & Peptide Letters Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans
Current Drug Metabolism Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Isolation, Synthesis and Biomimetic Reactions of Metalloporphyrinoids in Ionic Liquids
Current Organic Synthesis Unconventional Interaction Forces in Protein and Protein-ligand Systems and their Impacts to Drug Design
Current Topics in Medicinal Chemistry Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension
Current Drug Discovery Technologies GPCR Drug Discovery: Novel Ligands for CNS Receptors
Recent Patents on CNS Drug Discovery (Discontinued)